HUSSMAN STRATEGIC ADVISORS, INC. - EXELIXIS INC ownership

EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 7 filers reported holding EXELIXIS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 11.4%.

Quarter-by-quarter ownership
HUSSMAN STRATEGIC ADVISORS, INC. ownership history of EXELIXIS INC
ValueSharesWeighting
Q3 2023$2,840,500
+14.3%
130,0000.0%0.54%
+18.6%
Q2 2023$2,484,300
-17.4%
130,000
-16.1%
0.46%
-3.2%
Q1 2023$3,008,550
+21.0%
155,0000.0%0.47%
+16.5%
Q4 2022$2,486,200
+2.3%
155,0000.0%0.40%
-3.3%
Q3 2022$2,430,000
+349.2%
155,000
+496.2%
0.42%
+350.5%
Q2 2022$541,000
-8.1%
26,0000.0%0.09%
-18.4%
Q1 2022$589,000
+3.9%
26,000
-16.1%
0.11%
-8.1%
Q4 2021$567,000
-13.4%
31,0000.0%0.12%
-13.9%
Q3 2021$655,000
-42.0%
31,000
-50.0%
0.14%
-38.5%
Q2 2021$1,130,000
-45.9%
62,000
-33.0%
0.23%
-45.6%
Q1 2021$2,090,000
+1.6%
92,500
-9.8%
0.43%
-20.2%
Q4 2020$2,057,000
+10.0%
102,500
+34.0%
0.54%
+8.9%
Q3 2020$1,870,000
+3.0%
76,5000.0%0.50%
+6.9%
Q2 2020$1,816,000
-17.0%
76,500
-39.8%
0.46%
-21.5%
Q1 2020$2,187,000
+21.7%
127,000
+24.5%
0.59%
+3.1%
Q4 2019$1,797,000
-0.4%
102,0000.0%0.57%
+11.9%
Q3 2019$1,804,000102,0000.51%
Other shareholders
EXELIXIS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Meditor Group Ltd 17,416,738$422,007,00064.06%
Matrix Capital Management Company, LP 15,117,460$366,296,00011.71%
Rhenman & Partners Asset Management AB 1,050,000$25,442,0003.25%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 254,334$6,163,0002.40%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 790,148$19,145,0001.30%
Jupiter Investment Management Ltd 4,182,760$101,348,0001.06%
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC 50,818$1,231,0000.70%
C M BIDWELL & ASSOCIATES LTD 17,475$423,0000.65%
QCM Cayman, Ltd. 9,562$232,0000.60%
Handelsinvest Investeringsforvaltning 98,500$2,387,0000.56%
View complete list of EXELIXIS INC shareholders